Bryan M. Gannon

Bryan M. Gannon

Auto-generated profile, based on publicly available information

Bryan M. Gannon

Department of Nutritional Sciences, University of Wisconsin-Madison

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in The Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
STSherry A Tanumihardjo
Sherry A Tanumihardjo
RRRobert M Russell
Robert M Russell
CSCharles B Stephensen
Charles B Stephensen
BGBryan M Gannon
Bryan M Gannon
NCNeal E Craft
Neal E Craft
DRDan Raiten
Dan Raiten
The Biomarkers of Nutrition for Development (BOND) project is designed to provide evidence-informed advice to anyone with an interest in the role of

1 August 2015 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
SMStephanie Mondloch
Stephanie Mondloch
BGBryan M Gannon
Bryan M Gannon
CDChristopher R Davis
Christopher R Davis
JCJustin Chileshe
Justin Chileshe
CKChisela Kaliwile
Chisela Kaliwile
STSherry Tanumihardjo
Sherry Tanumihardjo
Background: Biomarkers of micronutrient status are needed to best define deficiencies and excesses of essential nutrients.Objective: We evaluated seve

1 October 2020 in Current Developments in Nutrition
Verified
Journal Article
Open access
BGBryan M Gannon
Bryan M Gannon
CJCamille Jones
Camille Jones
Saurabh MehtaSaurabh Mehta
Saurabh Mehta
Pregnancy and lactation are critical life stages with unique nutritional requirements, including for vitamin A (VA). Current DRIs for VA were published in 2001. The objective of this review was to identify and categorize evidence related to VA requirements in pregnancy and lactation since these DRIs were formulated. We searched MEDLINE and included articles according to an analytic framework of maternal VA exposure on status and health outcomes in the mother-child dyad. Intermediate and indirect evidence supports that maternal VA intakes can impact the mother's VA status, breastmilk, and health outcomes, as well as the child's VA status and select health outcomes. Food-based approaches can lead to more sustained, sufficient VA status in mothers and children. Research needs include further study linking maternal VA intakes on maternal and child VA status, and further associations with outcomes to determine intake requirements to optimize health.

13 August 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
CRCaleb J Ruth
Caleb J Ruth
Samantha Lee HueySamantha Lee Huey
Samantha Lee Huey
JKJesse T Krisher
Jesse T Krisher
AFAmy Fothergill
Amy Fothergill
BGBryan M Gannon
Bryan M Gannon
Saurabh MehtaSaurabh Mehta
Saurabh Mehta
Background: When we were unable to identify an electronic data capture (EDC) package that supported our requirements for clinical research in resource-limited regions, we set out to build our own reusable EDC framework. We needed to capture data when offline, synchronize data on demand, and enforce strict eligibility requirements and complex longitudinal protocols. Based on previous experience, the geographical areas in which we conduct our research often have unreliable, slow internet access that would make web-based EDC platforms impractical. We were unwilling to fall back on paper-based data capture as we wanted other benefits of EDC. Therefore, we decided to build our own reusable software platform. In this paper, we describe our customizable EDC framework and highlight how we have used it in our ongoing surveillance programs, clinic-based cross-sectional studies, and randomized controlled trials (RCTs) in various settings in India and Ecuador. Objective: This paper describes the creation of a mobile framework to support complex clinical research protocols in a variety of settings including clinical, surveillance, and RCTs. Methods: We developed ConnEDCt, a mobile EDC framework for iOS devices and personal computers, using Claris FileMaker software for electronic data capture and data storage. Results: ConnEDCt was tested in the field in our clinical, surveillance, and clinical trial research contexts in India and Ecuador and continuously refined for ease of use and optimization, including specific user roles; simultaneous synchronization across multiple locations; complex randomization schemes and informed consent processes; and collecting diverse types of data (laboratory, growth measurements, sociodemographic, health history, dietary recall and feeding practices, environmental exposures, and biological specimen collection). Conclusions: ConnEDCt is customizable, with regulatory-compliant security, data synchronization, and other useful features for data collection in a variety of settings and study designs. Furthermore, ConnEDCt is user friendly and lowers the risks for errors in data entry because of real time error checking and protocol enforcement.

1 May 2017 in The Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
BGBryan M Gannon
Bryan M Gannon
CDChristopher R Davis
Christopher R Davis
NNNivedita Nair
Nivedita Nair
MGMichael Grahn
Michael Grahn
STSherry Tanumihardjo
Sherry Tanumihardjo
Background: Neonatal vitamin A (VA) supplementation is being evaluated as a public health policy for preventing infant mortality, but inconsistencies

12 October 2018 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
TTTyler Titcomb
Tyler Titcomb
JSJesse Sheftel
Jesse Sheftel
MSMargaret Sowa
Margaret Sowa
BGBryan M Gannon
Bryan M Gannon
CDChristopher R Davis
Christopher R Davis
STSherry Tanumihardjo
Sherry Tanumihardjo
Biofortification of staple crops with β-carotene is a strategy to reduce vitamin A deficiency, and several varieties are available in some African countries. β-Cryptoxanthin (BCX)-enhanced maize is currently in field trials. To our knowledge, maize BCX bioavailability has not been assessed in humans. Serum retinol 13C content and xanthophyll concentrations are proposed effectiveness biomarkers for biofortified maize adoption. We determined the relative difference in BCX and zeaxanthin bioavailability from whole-grain and refined BCX-biofortified maize during chronic feeding compared with white maize and evaluated short-term changes in 13C-abundance in serum retinol. After a 7-d washout, 9 adults (mean ± SD age: 23.4 ± 2.3 y; 5 men) were provided with muffins made from BCX-enhanced whole-grain orange maize (WGOM), refined orange maize (ROM), or refined white maize (RWM) for 12 d in a randomized, blinded, crossover study followed by a 7-d washout. Blood was drawn on days 0, 3, 6, 9, 12, 15, and 19. Carotenoid areas under the curve (AUCs) were compared by using a fixed-effects model. 13C-Abundance in serum retinol was determined by using gas chromatography/combustion/isotope-ratio mass spectrometry on days 0, 12, and 19. Vitamin A status was determined by 13C-retinol isotope dilution postintervention. The serum BCX AUC was significantly higher for WGOM (1.70 ± 0.63 μmol ⋅ L−1 ⋅ d) and ROM (1.66 ± 1.08 μmol ⋅ L−1 ⋅ d) than for RWM (−0.06 ± 0.13 μmol ⋅ L−1 ⋅ d; P < 0.003). A greater increase occurred in serum BCX from WGOM muffins (131%) than from ROM muffins (108%) (P ≤ 0.003). Zeaxanthin AUCs were higher for WGOM (0.94 ± 0.33) and ROM (0.96 ± 0.47) than for RWM (0.05 ± 0.12 μmol ⋅ L−1 ⋅ d; P < 0.003). The intervention did not affect predose serum retinol 13C-abundance. Vitamin A status was within an optimal range (defined as 0.1–0.7 μmol/g liver). BCX and zeaxanthin were highly bioavailable from BCX-biofortified maize. The adoption of BCX maize could positively affect consumers’ BCX and zeaxanthin intakes and associated health benefits. This trial is registered at www.clinicaltrials.gov as NCT02800408.